Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,594 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Siglec-15 on Osteoclasts Is Crucial for Bone Erosion in Serum-Transfer Arthritis.
Korn MA, Schmitt H, Angermüller S, Chambers D, Seeling M, Lux UT, Brey S, Royzman D, Brückner C, Popp V, Percivalle E, Bäuerle T, Zinser E, Winkler TH, Steinkasserer A, Nimmerjahn F, Nitschke L. Korn MA, et al. Among authors: schmitt h. J Immunol. 2020 Nov 15;205(10):2595-2605. doi: 10.4049/jimmunol.2000472. Epub 2020 Oct 5. J Immunol. 2020. PMID: 33020147
Siglec-H-Deficient Mice Show Enhanced Type I IFN Responses, but Do Not Develop Autoimmunity After Influenza or LCMV Infections.
Szumilas N, Corneth OBJ, Lehmann CHK, Schmitt H, Cunz S, Cullen JG, Chu T, Marosan A, Mócsai A, Benes V, Zehn D, Dudziak D, Hendriks RW, Nitschke L. Szumilas N, et al. Among authors: schmitt h. Front Immunol. 2021 Aug 23;12:698420. doi: 10.3389/fimmu.2021.698420. eCollection 2021. Front Immunol. 2021. PMID: 34497606 Free PMC article.
Absence of Siglec-H in MCMV infection elevates interferon alpha production but does not enhance viral clearance.
Puttur F, Arnold-Schrauf C, Lahl K, Solmaz G, Lindenberg M, Mayer CT, Gohmert M, Swallow M, van Helt C, Schmitt H, Nitschke L, Lambrecht BN, Lang R, Messerle M, Sparwasser T. Puttur F, et al. Among authors: schmitt h. PLoS Pathog. 2013;9(9):e1003648. doi: 10.1371/journal.ppat.1003648. Epub 2013 Sep 26. PLoS Pathog. 2013. PMID: 24086137 Free PMC article.
The TLR9 Agonist Cobitolimod Induces IL10-Producing Wound Healing Macrophages and Regulatory T Cells in Ulcerative Colitis.
Schmitt H, Ulmschneider J, Billmeier U, Vieth M, Scarozza P, Sonnewald S, Reid S, Atreya I, Rath T, Zundler S, Langheinrich M, Schüttler J, Hartmann A, Winkler T, Admyre C, Knittel T, Dieterich Johansson C, Zargari A, Neurath MF, Atreya R. Schmitt H, et al. J Crohns Colitis. 2020 May 21;14(4):508-524. doi: 10.1093/ecco-jcc/jjz170. J Crohns Colitis. 2020. PMID: 31630153 Free PMC article. Clinical Trial.
Role of the IL23/IL17 Pathway in Crohn's Disease.
Schmitt H, Neurath MF, Atreya R. Schmitt H, et al. Front Immunol. 2021 Mar 30;12:622934. doi: 10.3389/fimmu.2021.622934. eCollection 2021. Front Immunol. 2021. PMID: 33859636 Free PMC article. Review.
Oligonucleotides-A Novel Promising Therapeutic Option for IBD.
Scarozza P, Schmitt H, Monteleone G, Neurath MF, Atreya R. Scarozza P, et al. Among authors: schmitt h. Front Pharmacol. 2019 Apr 24;10:314. doi: 10.3389/fphar.2019.00314. eCollection 2019. Front Pharmacol. 2019. PMID: 31068803 Free PMC article. Review.
Extent of Mucosal Inflammation in Ulcerative Colitis Influences the Clinical Remission Induced by Vedolizumab.
Scarozza P, Marafini I, Laudisi F, Troncone E, Schmitt H, Lenti MV, Costa S, Rocchetti I, De Cristofaro E, Salvatori S, Frezzati L, Di Sabatino A, Atreya R, Neurath MF, Calabrese E, Monteleone G. Scarozza P, et al. Among authors: schmitt h. J Clin Med. 2020 Feb 1;9(2):385. doi: 10.3390/jcm9020385. J Clin Med. 2020. PMID: 32024071 Free PMC article.
Resolution of Crohn's disease.
Schmitt H, Neufert C, Neurath MF, Atreya R. Schmitt H, et al. Semin Immunopathol. 2019 Nov;41(6):737-746. doi: 10.1007/s00281-019-00756-1. Epub 2019 Sep 24. Semin Immunopathol. 2019. PMID: 31552470 Review.
1,594 results